<DOC>
	<DOCNO>NCT02743390</DOCNO>
	<brief_summary>Resistant hypertension ( RH ) characterize high blood pressure ( BP ) spite concurrent use three antihypertensive agent different class , combine optimal dos . Currently largely discuss influence inflammation RH . The BP variation promotes increase expression pro-inflammatory cytokine , tumor necrosis factor-alpha , interleukins 1 6 . It show treatment TNF-α inhibitor improve BP endothelial function , reduce arterial stiffness patient rheumatoid arthritis . Recently , demonstrate TNF-α level increase RH subject compare normotensives . This study aim ass whether acute inhibition TNF-α change hemodynamic parameter , mean BP level RH .</brief_summary>
	<brief_title>Effects TNF-alpha Inhibiton Hemodynamic Parameters Resistant Hypertension</brief_title>
	<detailed_description>This crossover , double-blind study include 12 resistant hypertensive subject - regularly follow Outpatient Resistant Hypertension Clinic/UNICAMP - randomize assign ( 1 ) saline infusion follow infliximab infusion ( TNF-α inhibitor , 3 mg/kg ) ( 2 ) infliximab follow saline , two hour washout 40-day period infusion . It expect TNF-α inhibition regulate hemodynamic parameter , mean BP , cardiac Output , total peripheral resistance , may allow good rational approach RH treatment .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>diagnosis recommend AHA Statment Resistant Hypertension ( 2008 ) 6month period clinic followup give write informed consent form secondary Hypertension pseudoresistance hypertension ( poor medication adherence white coat hypertension ) patient symptomatic ischemic heart disease , impaired renal function , liver disease history stroke , myocardial infarction peripheral vascular disease pregnant woman smoke autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>blood pressure</keyword>
	<keyword>inflammation</keyword>
	<keyword>tumor Necrosis Factor-alpha</keyword>
</DOC>